|1.||Joo, Young-Eun: 6 articles (04/2014 - 12/2011)|
|2.||Park, Young-Lan: 6 articles (04/2014 - 12/2011)|
|3.||Jung, Young Do: 4 articles (04/2015 - 09/2010)|
|4.||Lee, Wan-Sik: 4 articles (09/2012 - 12/2011)|
|5.||Cho, Sung-Bum: 4 articles (09/2012 - 12/2011)|
|6.||Kim, Kyu-Yeol: 4 articles (09/2012 - 12/2011)|
|7.||Ammanamanchi, Sudhakar: 4 articles (09/2011 - 02/2008)|
|8.||Khoi, Pham Ngoc: 3 articles (04/2015 - 02/2011)|
|9.||Joo, Young Eun: 3 articles (03/2013 - 09/2010)|
|10.||Park, Jung Sun: 3 articles (03/2013 - 09/2010)|
10/05/2011 - "Splicing factor hnRNPH, which is upregulated in gliomas, controls this splicing event and similarly mediates switching to a ligand-independent, constitutively active Recepteur d'Origine Nantais (RON) tyrosine kinase receptor variant that promotes migration and invasion. "
02/01/2011 - "In glioma cells, MitA reduced the secretion and activity of the migration-involved matrix metalloproteinases (MMP), diminished vascular endothelial growth factor (VEGF), and increased recepteur d'origine nantais (RON) kinase messenger RNA (mRNA), paralleled by a significant reduction of glioma cell migration. "
07/01/2015 - "The proto-oncogene recepteur d'origine nantais (RON, MST1R) and its alternatively spliced variants are involved in various tumor biological processes, such as cell motility, adhesion, proliferation, apoptosis and epithelial-to-mesenchymal transition (EMT). "
07/01/2015 - "The overexpression of mesenchymal-epithelial transition factor (MET) and recepteur d'origine nantais (RON) has been shown to be associated with poor prognosis in some types of cancer. "
04/01/2015 - "Recepteur d'origine Nantais (RON) has been reported to play an important role in the cancer cell invasion process. "
04/01/2014 - "Several human tumor tissues show an aberrant expression and activation of recepteur d'origine nantais (RON). "
05/01/2013 - "Integrative genomic analyses of recepteur d'origine nantais and its prognostic value in cancer."
|3.||Colorectal Neoplasms (Colorectal Cancer)
09/01/2012 - "The aims of the current study were to evaluate whether recepteur d'origine nantais (RON) affects tumor cell behavior and oncogenic signaling pathways in colorectal cancer, and to examine the relationship of its expression with various clinicopathological parameters and patient survival. "
08/01/2008 - "Although Recepteur d'Origine Nantais (RON), a member of the MET receptor tyrosine kinase family, is overexpressed and constitutively active in some primary tumors and tumor cell lines, its expression pattern and clinical significance in colorectal cancer are not well documented. "
|4.||Prostatic Neoplasms (Prostate Cancer)
10/01/2015 - "Recepteur d'origine nantais (RON), more than a kinase: Role in castrate-resistant prostate cancer."
08/01/2010 - "The present study investigated the impact of the differential expression of TGase-4 in human prostate cancer cells on RON, the hepatocyte growth factor-like/macrophage-stimulating protein (HGF-L/MSP) receptor, mediated cellular functions. "
|5.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/01/2013 - "The purpose of this study was to investigate expression of recepteur d'origine nantais (RON) in human hypopharyngeal squamous cell carcinoma (SCC) and to determine whether RON affects tumor cell behavior in hypopharyngeal SCC cell line and if this would serve as a target for molecular therapy in a preclinical model. "
04/01/2014 - "RON (recepteur d'origine nantais) expression and its association with tumor progression in laryngeal squamous cell carcinoma."
|2.||Messenger RNA (mRNA)
|3.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|5.||macrophage stimulating protein
|6.||Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
|7.||tyrosine receptor (receptor, tyrosine)
|8.||Protein-Tyrosine Kinases (Tyrosine Kinase)
|9.||Small Interfering RNA (siRNA)
|10.||Urokinase Plasminogen Activator Receptors